
- Telehealth Visits
- Insurance plan information

Susan M. Chang, MD
Neuro-Oncology- Telehealth Visits
- Insurance plan information



Susan M. Chang, MD
Neuro-Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Susan Chang is a neuro-oncologist who specializes in treating adults with brain tumors. She is director of neuro-oncology at the Brain Tumor Center.
Chang also performs studies of experimental brain tumor treatments and evaluates the use of imaging techniques as treatment tools. Specifically, she was one of the recipients of a SPORE grant for evaluating the role of magnetic resonance spectroscopy in diagnosing tumors and evaluating therapeutic interventions. SPORE, which stands for Specialized Programs of Research Excellence, is a program of the National Cancer Institute. She is a principal investigator of a research project funded by the National Institutes of Health that focuses on optimizing the management of patients with glioblastoma, an aggressive brain cancer that's difficult to treat.
In addition, Chang is medical director of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, developed to address the needs of family members and others who care for patients with brain tumors.
Chang received her medical degree from the University of British Columbia and completed a residency in internal medicine at Plains Health Centre and Toronto General Hospital. She completed a fellowship in medical oncology at Princess Margaret Hospital in Toronto as well as a fellowship in neuro-oncology at UCSF, where she later joined the faculty.
Education & training
Fellowship
- Neuro-Oncology, UCSF Graduate Medical Education
- Medical Oncology & Hematology, Princess Margaret Hospital
Residency
- Medicine, Plains Health Centre -- CLOSED 1999
- Internal Medicine, University of Toronto Hospitals GME
Internship
- Rotating, Pasqua Hosp
Degree
- MD, University of British Columbia
My expertise
Specialties
Conditions
- Spinal Cord Tumors
- Primary Brain Tumor
- Pituitary Tumor
- Acromegaly
My work

Unique program supports loved ones caring for patients with brain cancer
My research
Clinical trials
Hyperpolarized Imaging in Diagnosing Participants With GliomaOpens in a new window
Recruiting
Adverse events will be monitored from just before investigational medicinal product (IMP) administration until the end of study participation. Vital signs…Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade GliomaOpens in a new window
Recruiting
Safety evaluation for endpoint will include monitoring for the occurrence of treatment-emergent adverse events (AEs). Reported toxicities will be graded using…Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant GliomaOpens in a new window
Recruiting
Signal-to-noise ratio (SNR) of HP 13C-aKG will be calculated voxel-by-voxel, and within each region of interest (ROI). The parameters considered will be the…
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.